| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.199 | 36.494 | 15.777 | 47.850 | 58.338 | 45.294 | 49.854 | 56.889 | 81.024 | 482 |
| Total Income - EUR | 42.199 | 36.494 | 15.777 | 47.850 | 58.338 | 45.294 | 49.854 | 56.889 | 81.024 | 482 |
| Total Expenses - EUR | 40.252 | 37.252 | 19.060 | 44.437 | 53.259 | 42.938 | 47.115 | 53.519 | 70.599 | 1.119 |
| Gross Profit/Loss - EUR | 1.947 | -759 | -3.282 | 3.413 | 5.079 | 2.357 | 2.739 | 3.369 | 10.426 | -637 |
| Net Profit/Loss - EUR | 681 | -1.164 | -3.440 | 2.947 | 4.495 | 1.904 | 2.240 | 2.800 | 9.582 | -663 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Farmapal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.529 | 4.292 | 4.033 | 3.775 | 3.522 | 3.279 | 3.034 | 2.914 | 2.732 | 2.545 |
| Current Assets | 16.211 | 28.165 | 58.064 | 54.153 | 40.707 | 47.672 | 55.580 | 64.334 | 9.842 | 2.803 |
| Inventories | 15.890 | 27.581 | 57.469 | 53.859 | 40.699 | 47.155 | 54.997 | 64.835 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 432 |
| Cash | 321 | 584 | 596 | 294 | 8 | 516 | 583 | -500 | 9.842 | 2.371 |
| Shareholders Funds | -15.144 | -16.154 | -19.321 | -16.019 | -11.213 | -9.096 | -6.654 | -3.875 | 5.719 | 5.024 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.884 | 48.612 | 81.418 | 73.947 | 55.442 | 60.047 | 65.268 | 71.123 | 6.856 | 324 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmapal Srl